BrightMEM is an innovative corneal allograft composed of Descemet’s Membrane that promotes corneal re-epithelialization and functions as a robust basement membrane with natural long-term durability – representing a new treatment for patients with impaired corneal healing.

Clinical Experience

• Approximately 90% of cases reported were fully healed within a mean healing time of 34.5 days

• For patients with follow-up care after 12 months, 100% reported complete re-epithelization

• More than half reported improved vision within a month – and vision reportedly continues to improve with time

• A successful graft retention rate of 92.7%

• Significant improvement in limbal cell growth demonstrated by an improved central staining grade from 3.2+ to 2.2+

• Neovascularization drops from an average of 71.4% to just 5.8%

• No infectious, inflammatory or rejection complications were reported